If you take a GLP-1 for a medical condition, such as Ozempic for diabetes or Wegovy to lower the risk of a heart attack or stroke, that coverage runs through your regular Part D plan, not the Bridge
Hospitals adoption of GLP-1 receptor agonists is driven by their ability to manage and treat diabetic patients with a variety of therapeutic options, from daily injections to newly available oral formulations
Mounjaro/Zepbound is a GLP-1 agonist like Ozempic and Wegovy
If youve struggled to lose weight with diet and exercise alone, these innovative treatments may provide the support your body needs to reset healthier habits and regain control
Some patients do better with temporary medication adjustments while others need alternative treatments
To view or add a comment, sign in I read through all 44 recommendations in the new ASCP deprescribing consensus statement